Open access
Aug 2026
Once-daily hypertonic saline inhalation and airway clearance techniques in children with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor: a prospective multicentre study.
Reduction to once-daily hypertonic saline inhalation and ACTs in children with CF treated with ETI was not associated with clinical deterioration over 12 months and was accompanied by reduced antibiotic use.
Marcus Svedberg, Christina Krantz, H. Imberg
· Journal of Cystic Fibrosis · 0 citations